Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma.
- Published in:
- Journal of Surgical Oncology, 2002, v. 80, n. 1, p. 52, doi. 10.1002/jso.10086
- By:
- Publication type:
- Article
Works by Pindolia, Kirit
Results: 7
1
2
Role of telomerase in anticancer activity of pristimerin in prostate cancer cells.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2015, v. 11, n. 1, p. 41
- By:
- Publication type:
- Article
3
Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 4, p. 1735, doi. 10.3892/ijo.2014.2561
- By:
- Publication type:
- Article
4
Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1604, doi. 10.1177/1352458515596457
- By:
- Publication type:
- Article
5
Developmental window of sensorineural deafness in biotinidase-deficient mice.
- Published in:
- Journal of Inherited Metabolic Disease, 2017, v. 40, n. 5, p. 733, doi. 10.1007/s10545-017-0049-z
- By:
- Publication type:
- Article
6
Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells.
- Published in:
- Oncology Reports, 2015, v. 34, n. 1, p. 518, doi. 10.3892/or.2015.3989
- By:
- Publication type:
- Article
7
Analysis of mutations causing biotinidase deficiency.
- Published in:
- 2010
- By:
- Publication type:
- Other